ModelEdge
Navidea Biopharmaceuticals, Inc.
NAVB
Filing type
8-K
Filing date
Nov 30, 2023
Updated
Dec 1, 2023 ยท 4:49 AM

Filing

8-KMaterial Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities

Exhibits

EX-10.1EXHIBIT 10.1EX-10.2EXHIBIT 10.2EX-10.3EXHIBIT 10.3EX-10.4EXHIBIT 10.4EX-99.1Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities